Neeleman Stephen 4

What Happened

• Stephen Neeleman, Founder and Vice Chairman (and Director) of HEALTHEQUITY, reported receipt of 39,775 restricted stock units (RSUs) on March 25, 2026. Of those, 23,860 RSUs vested on March 25, 2026 (footnote F2) and 15,915 RSUs were granted the same day (footnote F1). Both transactions show $0.00 per share (standard for RSU grants/vests), meaning no cash was paid by Neeleman.

Key Details

• Transaction date: March 25, 2026; filing date (Form 4): March 27, 2026 (appears timely).
• Transactions: 23,860 RSUs vested (acquired at $0.00); 15,915 RSUs newly granted (acquired at $0.00).
• Total RSUs involved: 39,775.
• Shares owned after transaction: not specified in the supplied filing details.
• Notable footnotes:
  • F1: The 15,915 RSUs vest 25% on April 1, 2027, then 6.25% each calendar quarter for the following 12 quarters.
  • F2: 23,860 RSUs vested on March 25, 2026 (now contingent rights converted to shares per filing).
  • F3–F5: Some securities are held of record by the Stephen & Christine Neeleman Trust and Neeleman Family Holdings, LLC; Neeleman disclaims beneficial ownership of certain shares except to the extent of his pecuniary interest, and some securities are beneficially owned by his spouse (disclaimer applies).
• This filing reports awards/vesting (code A) — not an open-market purchase or sale.

Context

• RSUs are a form of equity compensation: vested RSUs convert into shares (or cash equivalent) without the holder paying cash; newly granted RSUs are subject to the issuer’s vesting schedule described above.
• Awards and vesting are routine executive compensation events and do not by themselves indicate a buy/sell sentiment. The vested portion (23,860) became effective immediately; the granted portion (15,915) will vest over time under the schedule in F1.
• The filing includes standard trust/LLC and spouse disclaimers about beneficial ownership (see F3–F5).